Products for Research Use Only

GW3965

CAT: 0804-HY-10627-02Size: 10 mM - 1 mLDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-10627-02Size:10 mM - 1 mL
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
GW3965 is a potent, selective liver X receptor (LXR) agonist with EC50s of 190 nM and 30 nM for hLXRα and hLXRβ, respectively[1][2][3].
CAS Number
405911-09-3
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
LXR
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease; Vitamin D Related/Nuclear Receptor
Applications
Neuroscience-Neuromodulation
Field of Research
Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/GW3965.html
Purity
99.80
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
ClC1=C(C(F)(F)F)C=CC=C1CN(CC(C2=CC=CC=C2)C3=CC=CC=C3)CCCOC4=CC(CC(O)=O)=CC=C4
Molecular Formula
C33H31ClF3NO3
Molecular Weight
582.05
Precautions
H302, H315, H319, H335
References & Citations
[1]Mitro, Nico., et al. LXR and TSPO as new therapeutic targets to increase the levels of neuroactive steroids in the central nervous system of diabetic animals. Neurochemistry International (2012), 60 (6), 616-621.|[2]Guo, Deliang., et al. An LXR Agonist Promotes Glioblastoma Cell Death through Inhibition of an EGFR/AKT/SREBP-1/LDLR-Dependent Pathway. Cancer Discovery (2011), 1 (5), 442-456.|[3]Spyridon, Michael., et al. LXR as a novel antithrombotic target. Blood (2011), 117 (21), 5751-5761.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Citation 01
Am J Physiol Endocrinol Metab. 2019 Jun 1;316 (6) :E1136-E1145. |Bioconjug Chem. 2015 Nov 18;26 (11) :2216-22. |Biogerontology. 2025 Jan 31;26 (2) :49.|Brain Behav Immun. 2025 Aug 21:106089.|Cancer Lett. 2023 Jun 28:564:216208.|Cell Death Differ. 2020 Aug;27 (8) :2433-2450. |J Am Heart Assoc. 2021 May 18;10 (10) :e018455.|J Ethnopharmacol. 2023 Oct 28:315:116684.|MedComm (2020) . 2025 Sep 27;6 (10) :e70411.|Sci Adv. 2022 Jul 15;8 (28) :eabn5295.|SSRN. 2025 Aug 13.|Theranostics. 2020 Jul 11;10 (19) :8834-8850. |Vet Microbiol. 2024 Jan:288:109948.|bioRxiv. 2023 Mar 10.|Cytokine. 2025 May 7:191:156955.|Environ Int. 2024 Nov 26:194:109168.|Environ Sci Technol. 2025 May 6;59 (17) :8439-8450.|Immun Inflamm Dis. 2025 Aug;13 (8) :e70243.|Int Immunopharmacol. 2026 Jan 1;168 (Pt 2) :115878.|J Transl Med. 2025 May 14;23 (1) :542.|Nat Commun. 2025 Nov 6;16 (1) :9805.|Radboud University Nijmegen. 2021 Mar.|Viruses. 2022 Mar 3;14 (3) :514.

Chemical Information

3-(3-(((2-Chloro-3-(trifluoromethyl)phenyl)methyl)(2,2-diphenylethyl)amino)propoxy)benzeneacetic acid

GW 3965 is a diarylmethane.

CAS Number405911-09-3
PubChem CID447905
IUPAC Name2-[3-[3-[[2-chloro-3-(trifluoromethyl)phenyl]methyl-(2,2-diphenylethyl)amino]propoxy]phenyl]acetic acid
Molecular FormulaC33H31ClF3NO3
Molecular Weight582.0
XLogP5.9
Topological Polar Surface Area49.8
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count7
Rotatable Bond Count13
Heavy Atom Count41
Formal Charge0
Complexity753
SMILES
C1=CC=C(C=C1)C(CN(CCCOC2=CC=CC(=C2)CC(=O)O)CC3=C(C(=CC=C3)C(F)(F)F)Cl)C4=CC=CC=C4
InChI
InChI=1S/C33H31ClF3NO3/c34-32-27(15-8-17-30(32)33(35,36)37)22-38(18-9-19-41-28-16-7-10-24(20-28)21-31(39)40)23-29(25-11-3-1-4-12-25)26-13-5-2-6-14-26/h1-8,10-17,20,29H,9,18-19,21-23H2,(H,39,40)
InChIKey
NAXSRXHZFIBFMI-UHFFFAOYSA-N
Chemical Structure
2D Structure
2D structure of 3-(3-(((2-Chloro-3-(trifluoromethyl)phenyl)methyl)(2,2-diphenylethyl)amino)propoxy)benzeneacetic acid
CAS: 405911-09-3
CID: 447905
Formula: C33H31ClF3NO3
MW: 582.0
Interactive 3D Structure
Loading 3D structure...
Computed Properties
PropertyValue
Molecular Weight582.0
XLogP35.9
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count7
Rotatable Bond Count13
Exact Mass581.1944560
Monoisotopic Mass581.1944560
Topological Polar Surface Area49.8 Ų
Heavy Atom Count41
Formal Charge0
Complexity753
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently-Bonded Unit Count1
Compound Is CanonicalizedYes